Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Relative frequency and morphology of cancers in carriers of germline TP53 mutations.

Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM.

Oncogene. 2001 Aug 2;20(34):4621-8.

2.

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.

Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.

J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.

PMID:
20522432
3.

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM.

Oncogene. 1998 Sep 3;17(9):1061-8.

4.

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.

Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.

Cancer Lett. 2007 Jan 8;245(1-2):96-102. Epub 2006 Feb 21.

PMID:
16494995
5.

[When is it useful to look for TP53 germline gene mutations in families of oncology patients?].

Trková M, Sedlácek Z.

Cas Lek Cesk. 2003;142(4):220-5. Czech.

PMID:
12841124
6.

High frequency of germline p53 mutations in childhood adrenocortical cancer.

Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D.

J Natl Cancer Inst. 1994 Nov 16;86(22):1707-10.

PMID:
7966399
7.

Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.

van Hest LP, Ruijs MW, Wagner A, van der Meer CA, Verhoef S, van't Veer LJ, Meijers-Heijboer H.

Fam Cancer. 2007;6(3):311-6. Epub 2007 Feb 23.

PMID:
17318340
8.

[Germline mutations of the p53 gene].

Frebourg T.

Pathol Biol (Paris). 1997 Dec;45(10):845-51. Review. French.

PMID:
9769948
9.

High frequency of de novo mutations in Li-Fraumeni syndrome.

Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS.

J Med Genet. 2009 Oct;46(10):689-93. doi: 10.1136/jmg.2008.058958. Epub 2009 Jun 25.

PMID:
19556618
10.

Late-onset common cancers in a kindred with an Arg213Gln TP53 germline mutation.

Ruijs MW, Verhoef S, Wigbout G, Pruntel R, Floore AN, de Jong D, van T Veer LJ, Menko FH.

Fam Cancer. 2006;5(2):169-74.

PMID:
16736287
11.

[Li-Fraumeni syndrome].

Frebourg T.

Bull Cancer. 1997 Jul;84(7):735-40. Review. French.

12.

Germline TP53 mutations and Li-Fraumeni syndrome.

Varley JM.

Hum Mutat. 2003 Mar;21(3):313-20. Review. Erratum in: Hum Mutat. 2003 May;21(5):551.

PMID:
12619118
13.

Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.

Trkova M, Prochazkova K, Krutilkova V, Sumerauer D, Sedlacek Z.

Cancer. 2007 Aug 1;110(3):694-702.

14.

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.

Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Review.

PMID:
19952748
15.

A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla.

Patrikidou A, Bennett J, Abou-Sleiman P, Delhanty JD, Harris M.

Oral Oncol. 2002 Jun;38(4):383-90.

PMID:
12076704
16.

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.

Cancer Res. 2003 Oct 15;63(20):6643-50.

17.

Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.

Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.

Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.

18.

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA.

Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.

PMID:
27496084
19.

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.

Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11264-9. doi: 10.1073/pnas.0802970105. Epub 2008 Aug 6.

20.

TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.

Giacomazzi J, Selistre S, Duarte J, Ribeiro JP, Vieira PJ, de Souza Macedo G, Rossi C, Czepielewski M, Netto CB, Hainaut P, Ashton-Prolla P.

BMC Cancer. 2013 Apr 9;13:187. doi: 10.1186/1471-2407-13-187.

Supplemental Content

Support Center